Weijie Guo

7.4k citations
46 papers · 5.6k indexed · 2 hit papers · h-index 27

Weijie Guo

44 papers receiving 5.5k citations

Hit Papers

Circular RNA profiling reveals an abundant circHIPK3 that...1.6k201520262018202250010001.5k

Peers

Weijie Guo
Comparison fields: 5 of 116
  • Cancer Research 4.2k
  • Molecular Biology 5.1k
  • Immunology 210
  • Pathology and Forensic Medicine 131
  • Pulmonary and Respiratory Medicine 225
Replace Peiyu Pu with:
Peiyu Pu China
Hikaru Sonoda Japan
Qiwei Yang China
Khalid Bajou Belgium
Yu Xiang China
Mei Lin China
Ming Guan China
Minghui Wang China
Sweta Rani Ireland
Linhui Liang China
Weijie Guo relative to Peiyu Pu China Peiyu Pu's profile →
Citations per field
00.5×3.5×
Peiyu Pu · 1×
Citations per year

Countries citing papers authored by Weijie Guo

Since Specialization
Citations

This map shows the geographic impact of Weijie Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Guo more than expected).

Fields of papers citing papers by Weijie Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijie Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Guo. The network helps show where Weijie Guo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weijie Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weijie Guo Line = papers co-authored together Weijie Guo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202417
3 20246
4 202415
5 20235
6 202387
7 202214
8 202244
9 201918
10 201931
11 20195
12 201826
13
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAsbreakdown →
20161644
14 201577
15 2015100
16 201473
17 201462
18 201363
19 201248
20 2010151

About Weijie Guo

Weijie Guo is a scholar working on Cancer Research, Molecular Biology and Otorhinolaryngology, having authored 46 papers that have together received 5.6k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (13 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (9 papers), Circular RNAs in diseases (8 papers), RNA Interference and Gene Delivery (7 papers), Cancer-related molecular mechanisms research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Cancer Research (4.2k citations), Molecular Biology (5.1k citations) and Immunology (210 citations). Weijie Guo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xianghuo He, Shenglin Huang, Jianren Gu, Qiupeng Zheng, Chunyang Bao, Shuyi Li, Di Chen, Jiang Zhao, Yan Li and Linhui Liang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026